74 related articles for article (PubMed ID: 15480761)
1. p16INK4a expression and progression risk of low-grade intraepithelial neoplasia of the cervix uteri.
Negri G; Vittadello F; Romano F; Kasal A; Rivasi F; Girlando S; Mian C; Egarter-Vigl E
Virchows Arch; 2004 Dec; 445(6):616-20. PubMed ID: 15480761
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic utility of p16INK4a: a reappraisal of its use in cervical biopsies.
Mulvany NJ; Allen DG; Wilson SM
Pathology; 2008 Jun; 40(4):335-44. PubMed ID: 18446622
[TBL] [Abstract][Full Text] [Related]
3. Significance of Combined Analysis of High-Risk Human Papillomaviruses Polymerized Chain Reaction Analysis and Immunohistochemical Expression of p16INK4A in Cervical Cancer in a Cohort of South-Indian Population.
Sujatha T; Mullapudi Venkata S; Jayashankar E; Putcha UK; Koturu SK; Bhopal T; Neelala K; Chinta SK; Manjunathan R
Cureus; 2022 Sep; 14(9):e29001. PubMed ID: 36249643
[TBL] [Abstract][Full Text] [Related]
4. An Emerging Anti-p16 Antibody-BC42 Clone as an Alternative to the Current E6H4 for Use in the Female Genital Tract Pathological Diagnosis: Our Experience and a Review on p16ink4a Functional Significance, Role in Daily-Practice Diagnosis, Prognostic Potential, and Technical Pitfalls.
Angelico G; Santoro A; Inzani F; Straccia P; Spadola S; Arciuolo D; Valente M; D'Alessandris N; Benvenuto R; Travaglino A; Raffone A; Zannoni GF
Diagnostics (Basel); 2021 Apr; 11(4):. PubMed ID: 33923427
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of an adsorbent and anti-oxidative vaginal gel on CIN1 and 2, on high-risk HPV, and on p16/Ki-67: a randomized controlled trial.
Major AL; Dvořák V; Schwarzová J; Skřivánek A; Malík T; Pluta M; Mayboroda I; Grandjean EM
Arch Gynecol Obstet; 2021 Feb; 303(2):501-511. PubMed ID: 33219482
[TBL] [Abstract][Full Text] [Related]
6. p16INK4a and Ki-67 measurement predict progression of cervical low-grade squamous intraepithelial lesion.
Zhang X; Shen D
Int J Clin Exp Pathol; 2018; 11(8):4109-4116. PubMed ID: 31949802
[TBL] [Abstract][Full Text] [Related]
7. Progression of Precancerous Cervical Lesion Predicted by p16 Protein Immunohistochemistry in Rajavithi Hospital.
Charoonwatana T; Boonlikit S; Yanaranop M
Asian Pac J Cancer Prev; 2019 Jun; 20(6):1809-1815. PubMed ID: 31244304
[TBL] [Abstract][Full Text] [Related]
8. Utility of P16/INK4a and Ki-67 in Preneoplasticand Neoplastic Lesions of Cervix.
Sangwaiya A; Gill M; Bairwa S; Chaudhry M; Sen R; Prakash Kataria S
Iran J Pathol; 2018; 13(3):308-316. PubMed ID: 30636953
[TBL] [Abstract][Full Text] [Related]
9. Introduction of p16
Sarwath H; Bansal D; Husain NE; Mohamed M; Sultan AA; Bedri S
Infect Agent Cancer; 2017; 12():50. PubMed ID: 29021820
[TBL] [Abstract][Full Text] [Related]
10. Usefulness of p16
Miralpeix E; Genovés J; Maria Solé-Sedeño J; Mancebo G; Lloveras B; Bellosillo B; Alameda F; Carreras R
Mod Pathol; 2017 Feb; 30(2):304-310. PubMed ID: 27739439
[TBL] [Abstract][Full Text] [Related]
11. [Modern biomarkers for precancerous lesions of the uterine cervix : Histological-cytological correlation and use].
Schmidt D
Pathologe; 2016 Nov; 37(6):534-541. PubMed ID: 27638536
[TBL] [Abstract][Full Text] [Related]
12. TMEM45A, SERPINB5 and p16INK4A transcript levels are predictive for development of high-grade cervical lesions.
Manawapat-Klopfer A; Thomsen LT; Martus P; Munk C; Russ R; Gmuender H; Frederiksen K; Haedicke-Jarboui J; Stubenrauch F; Kjaer SK; Iftner T
Am J Cancer Res; 2016; 6(7):1524-36. PubMed ID: 27508094
[TBL] [Abstract][Full Text] [Related]
13. p16 staining has limited value in predicting the outcome of histological low-grade squamous intraepithelial lesions of the cervix.
Sagasta A; Castillo P; Saco A; Torné A; Esteve R; Marimon L; Ordi J; Del Pino M
Mod Pathol; 2016 Jan; 29(1):51-9. PubMed ID: 26541274
[TBL] [Abstract][Full Text] [Related]
14. Expression of P16 in high-risk human papillomavirus related lesions of the uterine cervix in a government hospital, Malaysia.
Krishnappa P; Mohamad IB; Lin YJ; Barua A
Diagn Pathol; 2014 Nov; 9():202. PubMed ID: 25361681
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical Expression of Cell Proliferating Nuclear Antigen (PCNA) and p53 Protein in Cervical Cancer.
Madhumati G; Kavita S; Anju M; Uma S; Raj M
J Obstet Gynaecol India; 2012 Oct; 62(5):557-61. PubMed ID: 24082558
[TBL] [Abstract][Full Text] [Related]
16. Cervical squamocolumnar junction-specific markers define distinct, clinically relevant subsets of low-grade squamous intraepithelial lesions.
Herfs M; Parra-Herran C; Howitt BE; Laury AR; Nucci MR; Feldman S; Jimenez CA; McKeon FD; Xian W; Crum CP
Am J Surg Pathol; 2013 Sep; 37(9):1311-8. PubMed ID: 24076771
[TBL] [Abstract][Full Text] [Related]
17. p16(INK4a) immunohistochemistry is a promising biomarker to predict the outcome of low grade cervical intraepithelial neoplasia: comparison study with HPV genotyping.
Nishio S; Fujii T; Nishio H; Kameyama K; Saito M; Iwata T; Kubushiro K; Aoki D
J Gynecol Oncol; 2013 Jul; 24(3):215-21. PubMed ID: 23875070
[TBL] [Abstract][Full Text] [Related]
18. p16(INK4a) immunoprofiles of squamous lesions of the uterine cervix-implications for the reclassification of atypical immature squamous metaplasia.
Skapa P; Robova H; Rob L; Zamecnik J
Pathol Oncol Res; 2013 Oct; 19(4):707-14. PubMed ID: 23686439
[TBL] [Abstract][Full Text] [Related]
19. Revised terminology for cervical histopathology and its implications for management of high-grade squamous intraepithelial lesions of the cervix.
Waxman AG; Chelmow D; Darragh TM; Lawson H; Moscicki AB
Obstet Gynecol; 2012 Dec; 120(6):1465-71. PubMed ID: 23168774
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
